“Stop distorted rumors,” regarding olmesartan issue
Pharmaceutical companies related to ‘olmesartan’ which is prohibited in health insurance benefit are under a state of emergency.
According to the pharmaceutical industry on the 15th, a number of patients started to refuse prescriptions after the news about its French suspension of the insurance ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
